IL-25 injections in human tumor xenograft models including melanoma, breast, lung, colon, and pancreatic cancers were shown to have antitumor efficacy with increased eosinophils in the peripheral blood of these mice12. The gene discussed is IL25; the disease is familial pancreatic carcinoma.